Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06228365

Minimally Invasive Superficial Venous Insufficiency Surgery and Digital Sedation

Virtual reality has been shown to reduce the pain experienced during medical procedures.

The aim of this study is to determine to what extent the use of this technique could make it possible to defer the administration of neuroleptanalgesia during the endovenous thermal treatment of superficial varicose veins in addition to local anaesthesia by tumescence.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinique de l'Union, Saint-Jean, France

Loading trial locations.

About this study

The main objective of the study is to test the non-inferiority of the effect of sedation by the virtual reality device on the intensity of maximum intraoperative pain compared with the usual neuroleptanalgesic treatment, tolerating a margin of non-inferiority of 0.5 points.Pain will be assessed on an ENS immediately at the end of the surgical procedure.

Prospective, randomised, open-label, single-centre study in two parallel groups of 200 patients.

Maximum duration of patient participation in the study = 2 days.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient aged 18 or over, who has read and signed the consent form for participation in the study after a reflection period (approximately 1 hour).
  • Outpatients with superficial venous insufficiency for which a surgical indication has been given
  • Patient requiring sedation associated with local anesthesia

Exclusion criteria

  • Contraindication to local anesthesia or any of the sedatives used in the protocol
  • Hearing or visual impairment contraindicating use of the virtual reality headset
  • Pregnant or breast-feeding patients
  • Unbalanced epilepsy
  • Patients under court protection, guardianship or curatorship
  • Patients not affiliated to the French social security system
  • Patient unable to understand informed information and/or give written informed consent: dementia, psychosis, disturbed consciousness, non-French-speaking patient

Treatment and study plan

use of a device incorporating virtual reality software

Device

use of a device incorporating virtual reality software

Neuroleptanalgesia

Drug

Usual neuroleptanalgesic treatment

Primary outcomes

  1. Pain intensity assessed by NRS (numerical rating scale)

    Time frame: Day 1

    The intensity of maximum pain during the surgery will be assessed by numerical rating scale (NRS) graduated from 0 (no pain) to 10 (worst pain imaginable).

Secondary outcomes

  1. Level of pre-operative anxiety assessed by the patient using the STAI-Y

    Time frame: Day 0

    The anxiety experienced will be assessed by the patient using the STAI-Y scale (Spielberg State Anxiety Inventory).

  2. Level of post-operative anxiety assessed by the patient using the STAI-Y

    Time frame: Day 1

    The anxiety experienced will be assessed by the patient using the STAI-Y scale (Spielberg State Anxiety Inventory).

  3. treatment administered during the procedure

    Time frame: Day 1

    Nature and quantities of additional sedative treatment administered during the procedure

  4. Pain intensity assessed by NRS (numerical rating scale)

    Time frame: Day 1

    Pain intensity assessed by NRS (numerical rating scale)

  5. Overall patient satisfaction post-opérative assessed by NRS (numerical rating scale)

    Time frame: Day 0

    Overall patient satisfaction will be assessed by NRS (numerical rating scale) graduated from 0 (not at all satisfied) to 10 (completely satisfied).

  6. Overall patient satisfaction day 1 assessed by NRS (numerical rating scale)

    Time frame: Day 1

    Overall patient satisfaction will be assessed by NRS (numerical rating scale) graduated from 0 (not at all satisfied) to 10 (completely satisfied).

  7. Surgery duration

    Time frame: Day 0

    Assessment of the surgery duration

  8. Length of stay in the ICU

    Time frame: Day 1

    Length of stay in the ICU

  9. Length of stay in the hospital

    Time frame: Day 1

    Length of stay in the hospital

  10. Resumption of current activities

    Time frame: Day 1

    Resumption of current activities measured by: YES or NO

Study contacts

Contact information is provided by the study sponsor or research team.

Lauranne MATRAY, MD

CONTACT

[email protected]

05 61 37 81 81 ext. 33

Sponsors and collaborators

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche

Other

Collaborators

  • Vivactis M2Research

Registry information

Official study title

Efficacy of Digital Sedation Compared With Neuroleptanalgesia in Percutaneous Outpatient Surgery for Superficial Venous Insufficiency

Acronym: CIMES

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jan 29, 2024
Registry last updated
Dec 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.